r tirzepatide compound Tirzepatide - Wikipedia
Description
Injection site considerations Both medications use subcutaneous injection, and the recommended sites are the same: abdomen, thigh, or upper arm
Wang L, Chen Y, Wei J, Guo F, Li L, Han Z, et al

Head-to-Head Comparison The most direct comparison came from the SURMOUNT-5 trial, which evaluated tirzepatide compared to semaglutide in adults with obesity

Moreover, it should not be given with food as it directly affects the bioavailability too
The beyond-use date assumes proper storage conditions have been maintained throughout the medications life, and any significant deviation from recommended storage conditions may necessitate earlier disposal

doi:10.1007/s00228-012-1214-9
